CVE-2020-36421

Public Exploit

Description

An issue was discovered in Arm Mbed TLS before 2.23.0. Because of a side channel in modular exponentiation, an RSA private key used in a secure enclave could be disclosed.

Category

5.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.19%
Third-Party Advisory gentoo.org Third-Party Advisory github.com Third-Party Advisory github.com Third-Party Advisory github.com Third-Party Advisory debian.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://github.com/ARMmbed/mbedtls/releases/tag/v2.16.7 third party advisory release notes
https://github.com/ARMmbed/mbedtls/releases/tag/v2.23.0 third party advisory release notes
https://github.com/ARMmbed/mbedtls/issues/3394 third party advisory issue tracking exploit
https://bugs.gentoo.org/730752 patch third party advisory issue tracking
https://lists.debian.org/debian-lts-announce/2022/12/msg00036.html third party advisory mailing list

Frequently Asked Questions

What is the severity of CVE-2020-36421?
CVE-2020-36421 has been scored as a medium severity vulnerability.
How to fix CVE-2020-36421?
To fix CVE-2020-36421, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-36421 being actively exploited in the wild?
It is possible that CVE-2020-36421 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.